Clinical Trials Arena on MSN
FDA finalises psychedelic clinical trial guidance
The FDA is holding a public hearing to talk through psychedelic drug development on 14 September.
The US Food and Drug Administration's finalized guidance on psychedelic drug development signals the agency remains receptive ...
Psychedelics: FDA offers clarifications, compromises in final clinical trial guidance FDA headquarters in Silver Spring, MD. (credit: Ferdous Al-Faruque) The US Food and Drug Administration (FDA) has ...
For years, the government and the public have been curious about the use of psychedelics for medicine. Beyond typical curiosity though, there have been real developments in recent years as to how to ...
You can’t call it cheatin’, she reminds me of you,” the Gin Blossoms sang on their 1996 album Congratulations I’m Sorry. For sponsors ...
The FDA's draft guidance could streamline biosimilar approval by reducing the need for comparative efficacy studies, emphasizing analytical assessments instead. This approach may lower development ...
A coalition of public health organizations, pediatricians and parents today filed a federal lawsuit challenging the Food and Drug Administration’s new enforcement policy that allows e-cigarette and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results